Abubakar Nazir

Abubakar Nazir


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2025
Verified
Book Chapter
Open access
PDF file
ANAbubakar Nazir
Abubakar Nazir
ANAwais Nazir
Awais Nazir
RZRabia Zaheer
Rabia Zaheer
HHHussam Haq
Hussam Haq
Tertiary care centers play a crucial role in the digital and green transformation of healthcare systems, especially in the context of controlling infectious diseases. The integration of digital technologies, such as telemedicine and artificial intelligence (AI), enhances disease surveillance, diagnosis, and patient management, thereby improving responsiveness to infectious outbreaks. Telemedicine facilitates remote consultations, reducing hospital crowding and exposure risks, while AI-driven systems enable faster and more accurate detection of infectious diseases, optimizing treatment protocols. Simultaneously, green practices, including energy-efficient infrastructure, sustainable waste management, and water conservation, reduce the environmental impact of healthcare facilities and minimize the spread of infection. The synergy between digital and green strategies strengthens the overall resilience of tertiary care in managing infectious diseases, fostering both healthcare efficiency and sustainability. This combined approach not only improves infection control but also contributes to the long-term sustainability and effectiveness of health systems globally.

16 January 2026 in Medicine
Verified
Journal Article
Open access
MAMaaz Amir
Maaz Amir
AHAhmad Hassan
Ahmad Hassan
EAEshah Fatima Ali
Eshah Fatima Ali
MNMeeram Noor
Meeram Noor
ANAbubakar Nazir
Abubakar Nazir
AHAhmad Haroon
Ahmad Haroon
Background: Structural heart disease (SHD) significantly increases the risk of life-threatening ventricular arrhythmias (VAs), contributing to sudden cardiac death. Implantable cardioverter-defibrillators are the cornerstone of prevention but do not eliminate arrhythmia recurrences or reduce the arrhythmogenic substrate. Catheter ablation has emerged as a potential adjunctive therapy to reduce VA burden and implantable cardioverter-defibrillator (ICD) interventions in patients with SHD. This meta-analysis aimed to evaluate the incremental benefits of catheter ablation compared to antiarrhythmic drug (AAD) therapy or standard care in patients with SHD undergoing ICD implantation for VAs. Methods: A systematic search was conducted till April 2025 across PubMed/MEDLINE, Cochrane, google scholar and science direct following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies included patients with SHD receiving ICD therapy, comparing catheter ablation with any alternative treatment. Outcomes assessed included mortality, arrhythmia recurrence, disease burden, and ICD interventions. Statistical analysis was performed using Review Manager, calculating odds ratios (ORs) and 95% confidence intervals (CI), with heterogeneity assessed via I 2 statistics. Results: Eight studies were included, encompassing 536 patients in the catheter ablation group and 560 patients in the control group. Catheter ablation did not significantly reduce all-cause mortality (OR = 0.79, 95% CI: 0.48–1.29, P = .34), cardiovascular mortality (OR = 0.73, 95% CI: 0.37–1.43, P = .36), or death (OR = 0.86, 95% CI: 0.53–1.38, P = .52). However, catheter ablation was associated with a significant reduction in recurrent ventricular tachycardia (VT) (OR = 0.42, 95% CI: 0.27–0.64, P < .001) and cardiac hospitalization (OR = 0.55, 95% CI: 0.34–0.89, P = .015). No significant differences were observed for VT storm or electrical storm. Importantly, catheter ablation significantly reduced inappropriate ICD shocks (OR = 0.36, 95% CI: 0.20–0.66, P < .001), while rates of appropriate ICD shocks and antitachycardia pacing were similar between groups. Conclusion: Catheter ablation offers significant benefits in reducing arrhythmia burden and inappropriate ICD shocks but does not impact overall mortality compared to antiarrhythmic therapy in patients with SHD undergoing ICD implantation.